These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14580033)

  • 1. The use of botulinum toxin in pediatric disorders.
    Gaebler-Spira D; Revivo G
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):703-25. PubMed ID: 14580033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
    Tilton AH
    J Child Neurol; 2003 Sep; 18 Suppl 1():S50-66. PubMed ID: 13677571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
    Koman LA; Paterson Smith B; Balkrishnan R
    Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic interventions for tone abnormalities in cerebral palsy.
    Tilton AH
    NeuroRx; 2006 Apr; 3(2):217-24. PubMed ID: 16554259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders.
    Yablon SA
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):833-74, vii-viii. PubMed ID: 11723867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of rimabotulinum toxin for focal hypertonicity management in children with cerebral palsy with nonresponse to onabotulinum toxin.
    Brandenburg JE; Krach LE; Gormley ME
    Am J Phys Med Rehabil; 2013 Oct; 92(10):898-904. PubMed ID: 23636084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with botulinum toxin in neurologic pediatrics].
    Justus N; Lee SH; Berweck S; Heinen F
    Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug treatment for children with cerebral palsy].
    Ben-Pazi H
    Harefuah; 2006 Jul; 145(7):510-5, 550. PubMed ID: 16900742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin for spasmodic dysphonia.
    Rodriquez AA
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):767-79. PubMed ID: 14580036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin: new option for refractory lower urinary tract symptoms in women.
    Rickey LM; Kenton K
    Clin Obstet Gynecol; 2008 Mar; 51(1):176-86. PubMed ID: 18303512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical Updates in Management of Hypertonia.
    Dy R; Roge D
    Phys Med Rehabil Clin N Am; 2020 Feb; 31(1):57-68. PubMed ID: 31760994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of oromandibular motor disorders and facial spasms with injections of botulinum toxin.
    Clark GT
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):727-48. PubMed ID: 14580034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of severe contractures might replace multilevel surgery in cerebral palsy: results of a population-based health care programme and new techniques to reduce spasticity.
    Hägglund G; Andersson S; Düppe H; Lauge-Pedersen H; Nordmark E; Westbom L
    J Pediatr Orthop B; 2005 Jul; 14(4):269-73. PubMed ID: 15931031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spasticity treatment with botulinum toxins.
    Ward AB
    J Neural Transm (Vienna); 2008; 115(4):607-16. PubMed ID: 18389166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin and its orthopaedic applications.
    Ramachandran M; Eastwood DM
    J Bone Joint Surg Br; 2006 Aug; 88(8):981-7. PubMed ID: 16877592
    [No Abstract]   [Full Text] [Related]  

  • 16. The importance of electromyographic guidance and electrical stimulation for injection of botulinum toxin.
    Childers MK
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):781-92. PubMed ID: 14580037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin--from threat to cure].
    Odergren T; Lennerstrand G; Lindestad PA; Hertegård S; Borg J
    Lakartidningen; 1996 Apr; 93(17):1619-24. PubMed ID: 8667769
    [No Abstract]   [Full Text] [Related]  

  • 18. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hyperhidrosis and drooling with botulinum exotoxin.
    Odderson IR
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):837-54. PubMed ID: 14580041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of botulinum toxin-B (BTX-B) injections for hemifacial spasm.
    Tousi B; Perumal JS; Ahuja K; Ahmed A; Subramanian T
    Parkinsonism Relat Disord; 2004 Oct; 10(7):455-6. PubMed ID: 15465407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.